Biblioteca Virtuale per la Salute – Piemonte – "Le biblioteche non si fanno…crescono" A. Birrell

Sfoglia per RIVISTA
AMERICAN JOURNAL OF HEMATOLOGY
Collezione AOU Città della Salute di Torino

Items : 48

Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report. in American journal of hematology / Am J Hematol. 2025 Mar;100(3):358-374. doi: 10.1002/ajh.27565. Epub 2024 Dec 23.

2025
AOU Alessandria
AOU Città della Salute di Torino

D?browska-Iwanicka A; Brunetti SC; Drozd-Soko?owska J; van den Ven L; Fianchi L; Limongelli A; Sciumè M; Leotta D; Bavastro M; Musto P; Delia M; Wolf D; Anastasopoulou AN; Mayer J; Víšek B; Varricchio G; Arellano E; Córdoba R; Cerchione C; Prin R; Cvetanoski M; Mitrovi? M; Aiello TF; Glenthøj A; Gräfe SK; Schönlein M; Hersby DS; Adži?-Vuki?evi? T; Coppola N; et alii...

First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategies. in American journal of hematology / Am J Hematol. 2025 Jan;100(1):189-191. doi: 10.1002/ajh.27524. Epub 2024 Nov 19.

2025
AO Ordine Mauriziano
AOU Città della Salute di Torino

Piazza F; Frustaci AM; Hohaus S; Zamprogna G; Peri V; Noto A; Scapinello G; Musto P; Pasquale R; Petrilli D; Stirparo L; Fresa A; Innocenti I; Motta M; Rossini B; Bullo M; Marino D; Ferrarini I; Cencini E; Puccini B; Rizzi R; Olivieri J; Danesin N; Galli E; Mattiello V; Benevolo G; Tedeschi A; Autore F; Ferrero S; et alii...

Impact of Pre-Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating Agents. in American journal of hematology / Am J Hematol. 2025 Apr;100(4):708-711. doi: 10.1002/ajh.27591. Epub 2025 Jan 20.

2025
AO Ordine Mauriziano
AOU Città della Salute di Torino

Brunetti L; Cilloni D; Lanza F; Cerchione C; Vertogen B; Zingaretti C; Cignetti A; Bernardi M; Mattei D; Nanni J; Palumbo FE; Ciccone N; Borlenghi E; Ciotti G; Rondoni M; Griguolo D; Gigli F; Vincenzo F; Zappasodi P; Martini G; Guolo F; Riva C; Minetto P; Audisio E; Papayannidis C; Martelli MP; Vetro C; Lanzarone G; Petracci E; et alii...

Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor-experienced patients with paroxysmal nocturnal hemoglobinuria. in American journal of hematology / Am J Hematol. 2024 Sep;99(9):1757-1767. doi: 10.1002/ajh.27413. Epub 2024 Jun 25.

2024
AOU Città della Salute di Torino

Kiialainen A; Gentile B; Buatois S; Panse J; Ueda Y; Lekue CB; Lee Y; Giai V; Hus M; Bonito D; Barcellini W; Yenerel MN; Nur E; Kim JS; Clé DV; Scheinberg P; Patel H; Sreckovic S; Uguen M; Edwards J; Nagy Z; Kulasekararaj AG;

Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study. in American journal of hematology / Am J Hematol. 2024 May;99(5):982-984. doi: 10.1002/ajh.27247. Epub 2024 Feb 11.

2024
AOU Città della Salute di Torino

Laurenti L; Pagano L; Innocenti I; Candoni A; Busca A; Trentin L; Tedeschi A; Marchesi F; Coscia M; Maschio N; Facchinelli D; Schiattone L; Sportoletti P; Del Principe MI; Scortechini I; Fazzi R; Sanna A; Olivieri J; Fresa A; Galli E; Vitale C; Visentin A; Deodato M; Autore F;

Peripheral blood stem cell versus bone marrow graft for patients ?60?years undergoing reduced intensity conditioning haploidentical transplantation for acute myeloid leukemia in complete remission: An analysis of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. in American journal of hematology / Am J Hematol. 2024 Jul;99(7):1250-1256. doi: 10.1002/ajh.27343. Epub 2024 May 23.

2024
AOU Città della Salute di Torino

Devillier R; Galimard JE; Blaise D; Raiola AM; Bramanti S; Grillo G; Pastano R; de Latour RP; Busca A; López-Corral L; Rodríguez AB; Schmid C; Forcade E; Vydra J; Solano C; Bug G; Neubauer A; Charbonnier A; Brissot E; Nagler A; Ciceri F; Mohty M;

An atypical presentation of visceral leishmaniasis mimicking multiple myeloma relapse. in American journal of hematology / Am J Hematol. 2024 Jan;99(1):137-141. doi: 10.1002/ajh.27147. Epub 2023 Nov 20.

2024
AOU Città della Salute di Torino

Bruno B; Maletta F; Bringhen S; Benevolo G; Bertuglia G;

Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial. in American journal of hematology / Am J Hematol. 2024 Aug;99(8):1462-1474. doi: 10.1002/ajh.27418. Epub 2024 Jun 15.

2024
AOU Città della Salute di Torino

Rocca B; Tosetto A; Petrucci G; Rossi E; Betti S; Soldati D; Iurlo A; Cattaneo D; Bucelli C; Dragani A; Di Ianni M; Ranalli P; Palandri F; Vianelli N; Beggiato E; Lanzarone G; Ruggeri M; Carli G; Elli EM; Renso R; Randi ML; Bertozzi I; Loscocco GG; Ricco A; Specchia G; Vannucchi AM; Rodeghiero F; De Stefano V; Patrono C; et alii...

Late-onset and long-lasting neutropenias in the young: A new entity anticipating immune-dysregulation disorders. in American journal of hematology / Am J Hematol. 2024 Apr;99(4):534-542. doi: 10.1002/ajh.27221. Epub 2024 Jan 29.

2024
AOU Città della Salute di Torino

Cangelosi D; Uva P; Del Borrello G; Lupia M; Terranova P; Coviello D; Grossi A; Ceccherini I; Lanciotti M; Civino A; Onofrillo D; Zanardi S; Marzollo A; Pillon M; Saettini F; Bagnasco F; Giarratana MC; Contratto C; Turrini E; Casartelli P; Beccaria A; Fioredda F; Cavalca G; Miano M; Dufour C;

Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study. in American journal of hematology / Am J Hematol. 2023 Sep;98(9):E237-E240. doi: 10.1002/ajh.27009. Epub 2023 Jun 29.

2023
AOU Città della Salute di Torino

Coscia M; Molica S; Laurenti L; Zatta I; Ruocco V; Cellini A; Angotzi F; Cavarretta CA; Trimarco V; Sportoletti P; Rigolin GM; Murru R; Marchetti M; Pietrasanta D; Sanna A; Vitale C; Cibien F; Derenzini E; Proietti G; Ferrarini I; Reda G; Farina L; Gentile M; Mauro FR; Scarfò L; Visentin A; Ghia P; Foà R; Cuneo A; et alii...

Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR-PRO study. in American journal of hematology / Am J Hematol. 2023 Nov;98(11):1762-1771. doi: 10.1002/ajh.27073. Epub 2023 Aug 30.

2023
AOU Città della Salute di Torino

Druker BJ; Piazza R; Stagno F; Saussele S; Maffioli M; Caocci G; Galimberti S; le Coutre P; Lunghi F; Cerrano M; Capodanno I; Iurlo A; Bucelli C; Triguero A; Alvarez-Larran A; Elena C; Miggiano MC; Abruzzese E; Pungolino E; Busque L; Assouline S; Nicolini FE; Zambrotta GPM; Fava C; Guglielmana V; Colombo F; Antolini L; Gambacorti-Passerini C;

Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real-World" study. in American journal of hematology / Am J Hematol. 2023 Feb;98(2):E24-E27. doi: 10.1002/ajh.26779. Epub 2022 Nov 25.

2023
AOU Città della Salute di Torino
AOU Novara

Herishanu Y; Perry C; Gattei V; Cuneo A; Foà R; Gaidano G; Trentin L; Rossi D; Neri A; Olivieri J; Zucchetto A; Bomben R; Pietrasanta D; Loseto G; Chiarenza A; Visentin A; Aviv A; Murru R; Braester A; Varettoni M; Coscia M; Tadmor T; Shvidel L; Laurenti L; Reda G; Ruchlemer R; Sportoletti P; Mauro FR; Gutwein O; et alii...

The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL. in American journal of hematology / Am J Hematol. 2023 Dec;98(12):1856-1868. doi: 10.1002/ajh.27093. Epub 2023 Sep 29.

2023
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

De Paoli L; De Paolis MR; Delgado J; Dimou M; Donaldson D; Catherwood M; Doubek M; Efstathopoulou M; Eichhorst B; Elashwah S; Enrico A; Espinet B; Farina L; Ferrari A; Stamatopoulos K; Ghia P; Stavroyianni N; Trentin L; Cuneo A; Montserrat E; Vitale C; Coscia M; Rambaldi A; Iyengar S; Varettoni M; Yassin M; Pocali B; Vandenberghe E; van Kampen R; et alii...

Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts. in American journal of hematology / Am J Hematol. 2023 Aug;98(8):E204-E208. doi: 10.1002/ajh.26960. Epub 2023 May 24.

2023
AOU Alessandria
ASL Città di Torino
ASL Torino 4
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Della Porta MG; Santini V; Naldi I; Finelli C; Sancetta R; Selleri C; Pasini P; Giordano L; Turrini M; Tosi P; Tanasi I; Frigeni M; Grimaldi D; Marchetti M; Norata M; Galimberti S; Fianchi L; Di Veroli A; Ferrara F; Di Bona E; Bono R; Castelli A; Calvisi A; Rivoli G; Molteni A; Nicolino B; Occhini U; Leuzzi L; Genua A; et alii...

Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model. in American journal of hematology / Am J Hematol. 2022 May;97(5):E176-E180. doi: 10.1002/ajh.26502. Epub 2022 Feb 25.

2022
AOU Città della Salute di Torino
AOU Novara

Trentin L; Foa' R; Cuneo A; Tedeschi A; Gaidano G; Coscia M; Guarente V; Noto A; Ielo C; Deodato M; Stelitano C; Del Poeta G; Giordano A; Levato L; Rigolin GM; Gentile M; Moia R; Murru R; De Paoli L; Laurenti L; Chiarenza A; Ciolli S; Vitale C; Frustaci AM; Mauro FR; Sportoletti P; Reda G; Visentin A; Giannarelli D; et alii...

Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study. in American journal of hematology / Am J Hematol. 2022 Mar 1;97(3):E95-E99. doi: 10.1002/ajh.26437. Epub 2021 Dec 21.

2022
AOU Città della Salute di Torino

Laurenti L; Molica S; Coscia M; Pravato S; Piazza F; Sportoletti P; Scarfò L; Quaglia FM; Rigolin GM; Gentile M; Murru R; Marchetti M; Pietrasanta D; Ciolli S; Fresa A; Vitale C; Reda G; Cibien F; Mauro FR; Visentin A; Foà R; Cuneo A; Trentin L;

SARS-CoV-2 vaccination in patients with paroxysmal nocturnal hemoglobinuria: An Italian multicenter survey. in American journal of hematology / Am J Hematol. 2022 Jul;97(7):E229-E232. doi: 10.1002/ajh.26545. Epub 2022 Mar 26.

2022
AOU Città della Salute di Torino

Sica S; Giglio F; Di Bona E; Beggiato E; Giai V; Lucchesi A; Apolito V; Visentin A; Metafuni E; Ielo C; Bortolotti M; Girmenia C; Fattizzo B; Giannotta JA; Iori AP; Barcellini W;

Safety and efficacy of polatuzumab vedotin?+?obinutuzumab for relapsed/refractory non-Hodgkin lymphomas: A phase IB/II study. in American journal of hematology / Am J Hematol. 2022 Jan 1;97(1):E24-E27. doi: 10.1002/ajh.26400. Epub 2021 Nov 30.

2022
AOU Città della Salute di Torino

Morschhauser F; Hirata J; Ramies D; Cheng J; Diefenbach C; Chiappella A; Essell J; Brunvand M; Chen AI; Phillips T; Flinn IW;

Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19. in American journal of hematology / Am J Hematol. 2022 Dec;97(12):E470-E473. doi: 10.1002/ajh.26732. Epub 2022 Sep 27.

2022
AOU Città della Salute di Torino
AOU Novara

Curto-Garcia N; Rambaldi A; Betti S; Bellini M; Borsani O; Cavalca F; Cichocka E; Cattaneo D; de Na??cz AK; Bucelli C; Koschmieder S; Navas Elorza B; Angona A; Xicoy Cirici B; Lopez Abadia E; Sagues Serrano M; Kusec R; Osorio S; Carreno-Tarragona G; Hernandez-Boluda JC; Magro Mazo E; Carli G; Garcia-Gutierrez V; Marin Sanchez A; Patriarca A; Quiroz Cervantes K; Griesshammer M; Bolaños Calderón E; Kiladjian JJ; et alii...

Human leukocyte antigen-haploidentical transplantation for relapsed/refractory acute myeloid leukemia: Better leukemia-free survival with bone marrow than with peripheral blood stem cells in patients??55?years of age. in American journal of hematology / Am J Hematol. 2022 Aug;97(8):1065-1074. doi: 10.1002/ajh.26627. Epub 2022 Jun 24.

2022
AOU Città della Salute di Torino

Koc Y; Diez-Martin JL; Busca A; Stölzel F; Vydra J; Fanin R; Sica S; Blaise D; Ciceri F; Raiola AM; Tischer J; Labopin M; Baron F; Nagler A; Mohty M;

The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30-year experience. in American journal of hematology / Am J Hematol. 2021 Oct 1;96(10):1204-1210. doi: 10.1002/ajh.26287. Epub 2021 Jul 23.

2021
AOU Città della Salute di Torino

Carella M; Lolli G; Morigi A; Casadei B; Pellegrini C; Stefoni V; Gabrielli G; Sabattini E; Terragna C; Nanni L; Argnani L; Broccoli A; Coppola PE; Zinzani PL;

Isatuximab plus pomalidomide and dexamethasone in frail patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis. in American journal of hematology / Am J Hematol. 2021 Nov 1;96(11):E423-E427. doi: 10.1002/ajh.26319. Epub 2021 Sep 23.

2021
AOU Città della Salute di Torino

Schjesvold F; Bringhen S; G Richardson P; Perrot A; Leleu X; Moreau P; A Dimopoulos M; Hulin C; Tekle C; Foster MC; Poole EM; van de Velde H; Facon T;

Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study. in American journal of hematology / Am J Hematol. 2021 May 1;96(5):E168-E171. doi: 10.1002/ajh.26127. Epub 2021 Feb 24.

2021
AOU Città della Salute di Torino
AOU Novara

Gattei V; Foà R; Ferrarini M; Trentin L; Polliack A; Gaidano G; Cuneo A; Di Raimondo F; Rossi D; Fronza G; Cutrona G; Neri A; Bomben R; Del Giudice I; Biagi A; Angeletti I; Rago A; D'Arrigo G; Galimberti S; Cassin R; Botta C; Caracciolo D; Mendicino F; Vigna E; Martino EA; Zucchetto A; Rossi FM; Scortechini I; Loseto G; et alii...

Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials. in American journal of hematology / Am J Hematol. 2021 Aug 1;96(8):E269-E272. doi: 10.1002/ajh.26201. Epub 2021 May 3.

2021
AOU Città della Salute di Torino
AOU Novara

Ferrarini M; Trentin L; Foà R; Polliack A; Di Raimondo F; Gaidano G; Cuneo A; Rossi D; Cutrona G; Olivieri J; Menichini P; Monti P; Neri A; Fronza G; Bomben R; Del Giudice I; Angeletti I; Biagi A; Galimberti S; Rago A; D Arrigo G; Martino EA; Cassin R; Vigna E; Al-Janazreh H; Rossi FM; Zucchetto A; Scortechini I; Consoli U; et alii...

Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era. in American journal of hematology / Am J Hematol. 2021 Aug 1;96(8):979-988. doi: 10.1002/ajh.26230. Epub 2021 May 27.

2021
AOU Città della Salute di Torino

Villarraga HR; Habermann TM; Nowakowski GS; Witzig TE; Allmer C; Maurer MJ; Thanarajasingam G; Inwards DJ; Herrmann J; Castellino A; Larson MC; Boddicker NJ; Slager SL; Cerhan JR; Thompson CA;

TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases. in American journal of hematology / Am J Hematol. 2021 Aug 1;96(8):E306-E310. doi: 10.1002/ajh.26235. Epub 2021 May 25.

2021
AOU Città della Salute di Torino
AOU Novara

Ferrarini M; Foà R; Trentin L; Polliack A; Gaidano G; Cuneo A; Olivieri J; Rossi D; Di Raimondo F; Cutrona G; Jaksic O; Fronza G; Neri A; Bomben R; Biagi A; Del Giudice I; Angeletti I; Galimberti S; Rago A; D'Arrigo G; Vigna E; Tripepi G; Martino EA; Al-Janazreh H; Zucchetto A; Rossi FM; Consoli U; Scortechini I; Recchia AG; et alii...

ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study. in American journal of hematology / Am J Hematol. 2020 Sep;95(9):1030-1037. doi: 10.1002/ajh.25871. Epub 2020 Jun 30.